Bide Pharmatech Co

Bide Pharmatech Co ROA

The Return on Assets (ROA) of Bide Pharmatech Co (688073.SS) as of Nov 4, 2026 is 6.03 %. In the previous year, Return on Assets (ROA) was 4.86 % — a change of 24.15% (higher).

ROA

6.03 %

YoY

24.15%

Last updated:

In 2025, Bide Pharmatech Co's return on assets (ROA) was 6.03 %, a 24.15% increase from the 4.86 % ROA in the previous year.

The Bide Pharmatech Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2020
11.09 CNY
Jan 1, 2021
10.77 CNY
Jan 1, 2022
6.19 CNY
Jan 1, 2023
4.54 CNY
Jan 1, 2024
4.86 CNY
Jan 1, 2025
6.03 CNY
The Bide Pharmatech Co ROA history
YEARROAYoY
6.03 %+24.15%
4.86 %+7.03%
4.54 %-26.67%
6.19 %-42.54%
10.77 %-2.93%
11.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bide Pharmatech Co Stock analysis

What does Bide Pharmatech Co do? Bide Pharmatech Co., Ltd. generates revenue through the research, development, design, production, and sales of pharmaceutical molecular building blocks and scientific reagents. The company's primary products serve drug target discovery, seed compound screening, lead compound discovery, synthesis, and optimization processes. Key markets include Asia Pacific, India, Europe, and the United States, where the firm's offerings are utilized by pharmaceutical companies and research institutions. The business model relies on direct sales of its specialized chemical products to these industry segments. The firm's main focus is on developing molecular building blocks for drug development, with products specifically designed for early-stage pharmaceutical research. These building blocks are essential for creating and refining potential drug candidates. The company's operations span multiple global regions, targeting pharmaceutical manufacturers and academic research organizations that require high-quality chemical compounds for their development pipelines. Bide Pharmatech's revenue streams are derived from the sale of its proprietary molecular building blocks and reagents, which are integral to pharmaceutical R&D processes. The company serves clients in the pharmaceutical sector across Asia Pacific, India, Europe, and the United States, delivering products that support critical stages of drug discovery and development. Bide Pharmatech Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding Bide Pharmatech Co's Return on Assets (ROA)

Bide Pharmatech Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Bide Pharmatech Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Bide Pharmatech Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Bide Pharmatech Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Bide Pharmatech Co stock

Return on Assets (ROA) of Bide Pharmatech Co is 6.03 % in 2025.

Return on Assets (ROA) of Bide Pharmatech Co changed from 4.86 % to 6.03 %, representing a 24.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Bide Pharmatech Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Bide Pharmatech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bide Pharmatech Co

All Key Metrics — Bide Pharmatech Co